BMRN vs SPIR · P/E 40, rev $2.85B vs rev $110.5M
Biomarin Pharmaceutical Inc (BMRN) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the BMRN and SPIR stock pages for the full models.
Not investment advice.